进入 11 月以来,我国医药健康领域喜讯不断。截至 11 月 7 日,国家药品监督管理局已先后批准 2 个创新药和 2 个医疗器械创新产品上市,涵盖肿瘤治疗、新冠感染治疗、心血管疾病治疗以及医学影像辅助诊断等多个关键领域,为广大患者带来福音,也彰显了我国医药创新的强劲实力。2个创新药获批上市11月7日国家药监局发布消息显示,通过优先审评审批程序附条件批准重庆精准生物技术有限公司申报的普基奥仑赛...
Source Link进入 11 月以来,我国医药健康领域喜讯不断。截至 11 月 7 日,国家药品监督管理局已先后批准 2 个创新药和 2 个医疗器械创新产品上市,涵盖肿瘤治疗、新冠感染治疗、心血管疾病治疗以及医学影像辅助诊断等多个关键领域,为广大患者带来福音,也彰显了我国医药创新的强劲实力。2个创新药获批上市11月7日国家药监局发布消息显示,通过优先审评审批程序附条件批准重庆精准生物技术有限公司申报的普基奥仑赛...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.